Prothena Corp Public Ltd Co (PRTA): Operating Income
-$214.64M
Year ended 2025-12-31
-$55.51M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$214.64M | n/m | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | -$154.56M | n/m | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | -$191.04M | n/m | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | -$131.56M | n/m | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $71.97M | n/m | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | -$112.73M | n/m | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | -$85.70M | n/m | 2022-02-25, From 2019-01-01 |
| 2018-12-31 | -$158.85M | n/m | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | -$155.25M | n/m | 2020-03-03, From 2017-01-01 |
| 2016-12-31 | -$159.53M | n/m | 2019-03-15, From 2016-01-01 |
| 2015-12-31 | -$79.94M | n/m | 2018-02-26, From 2015-01-01 |
| 2014-12-31 | -$6.65M | n/m | 2017-02-27, From 2014-01-01 |
| 2013-12-31 | -$40.43M | n/m | 2016-02-25, From 2013-01-01 |
| 2012-12-31 | -$41.41M | n/m | 2015-03-13, From 2012-01-01 |
| 2011-12-31 | -$29.24M | n/a | 2014-03-07, From 2011-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Prothena Corp Public Ltd Co (PRTA) | 2025-12-31 | -$214.64M | n/m |
| Precigen, Inc. (PGEN) | 2025-12-31 | -$110.51M | n/m |
| Janux Therapeutics, Inc. (JANX) | 2025-12-31 | -$157.67M | n/m |
| Zenas BioPharma, Inc. (ZBIO) | 2025-12-31 | -$383.06M | n/m |
| International Stem Cell Corp (ISCO) | 2025-12-31 | -$267.0K | n/m |
| BioAge Labs, Inc. (BIOA) | 2025-12-31 | -$92.78M | n/m |
| Crescent Biopharma, Inc. (CBIO) | 2025-12-31 | -$152.63M | n/m |
| Roivant Sciences Ltd. (ROIV) | 2026-03-31 | -$515.07M | n/m |
| Jaguar Health, Inc. (JAGX) | 2025-12-31 | -$45.91M | n/m |
Compare PRTA, PGEN, JANX, ZBIO side by side · Screen every company in Pharmaceutical Preparations ↗